Kennedy Capital Management’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.25M Buy
37,504
+1,075
+3% +$107K 0.08% 351
2026
Q1
$3.43M Buy
36,429
+2,989
+9% +$298K 0.07% 353
2025
Q4
$3.3M Buy
33,440
+489
+1% +$47.3K 0.07% 367
2025
Q3
$2.79M Buy
32,951
+16,107
+96% +$1.27M 0.06% 395
2025
Q2
$1.15M Buy
16,844
+578
+4% +$36.6K 0.03% 493
2025
Q1
$985K Buy
16,266
+208
+1% +$14.5K 0.02% 520
2024
Q4
$1.11M Buy
16,058
+2,696
+20% +$192K 0.02% 587
2024
Q3
$883K Buy
13,362
+1,919
+17% +$122K 0.02% 605
2024
Q2
$694K Buy
11,443
+3,319
+41% +$188K 0.01% 615
2024
Q1
$463K Buy
+8,124
New +$488K 0.01% 661

Other funds holding INCY

Kennedy Capital Management's INCY Position: Q2 2026 in Review

Kennedy Capital Management increased its Incyte (INCY) stake by 3% in Q2 2026, buying an estimated $107K and bringing the position to 37,504 shares worth $4.25M. The position accounts for 0.08% of the portfolio, ranked #351.

Kennedy Capital Management first reported a position in INCY in Q1 2024 and has held it in 10 quarters since. 858 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Kennedy Capital Management held 37,504 shares of Incyte worth $4.25M as of Q2 2026.
  • Kennedy Capital Management bought 1,075 Incyte shares in Q2 2026, an estimated $107K.
  • Incyte made up 0.08% of Kennedy Capital Management's portfolio in Q2 2026, its #351 holding.
  • Kennedy Capital Management first reported a position in Incyte in Q1 2024 and has held it in 10 quarters since.
  • 858 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.